Controlling the Covid-19 pandemic through Green Zones

The No-COVID Strategy

The No-COVID Strategy

In June/July of last year, Germany and many other European countries had reached a situation of low incidence after successfully bending the curves of the first surges of Covid-19. Restrictions were lifted progressively, and international travel was allowed again. When the numbers started to rise, first slowly, and then rapidly, non-pharmaceutical interventions were imposed late and reluctantly. The lack of both a structured exit strategy and a detailed plan for outbreak management steered many of the countries into difficult epidemiological situations and the next round of lockdowns.
The No-COVID Strategy aims at a safe and sustainable re-opening of societies and economies. It suggests pursuing the No-COVID goal, and, once this goal has been reached, applying the Green Zone Strategy to protect it. Several countries have successfully implemented this approach, thereby making it possible for their populations to return to a nearly normal life. For the Federal Republic of Germany and other European countries, too, this path is feasible and desirable — in terms of health, economy, and society.

No Infections

The number of infections is reduced to near zero.

No Transmissions

Transmissions and reintroductions of the virus into green zones are avoided through mobility restrictions, tests and quarantines.

No Negligence

If new cases occur, outbreaks are managed rigorously.


Scientists from different fields working on the No-COVID strategy

Prof. Dr. Menno Baumann

Education, Fliedner University of Applied Sciences, Düsseldorf

Dr. Markus Beier

Medicine, general practitioner, chairman of the Bavarian General Practitioner Association

Prof. Dr. Melanie Brinkmann

Virology, Helmholtz Center for Infection Research Braunschweig

Prof. Dr. Dirk Brockmann

Physics, Institute of Biology, Humboldt University of Berlin

Prof. Dr. Heinz Bude

Sociology, University of Kassel

Prof. Dr. Dr. h.c. Clemens Fuest

Economics, Ifo Institute and LMU Munich

Ass. Jur. Denise Feldner, M.B.L.

Law, Technology Law, Crowdhelix / KU Leuven Germany

Prof. Dr. Michael Hallek

Medicine, Internist, Clinic I for Internal Medicine, University of Cologne

Prof. Dr. Dr. h.c. Ilona Kickbusch

Global Public Health, Graduate Institute Geneva, WHO consultant, GPMB

Prof. Dr. Maximilian Mayer

Political Science, Asia, CASSIS, University of Bonn

Prof. Dr. Michael Meyer-Hermann

Physics, Helmholtz Center for Infection Research Braunschweig

Prof. Dr. Andreas Peichl

Economics, Ifo Institute and LMU Munich

Prof. Dr. Elvira Rosert

Political Science, Universtität Hamburg / Institute for Peace Research and Security Policy, IFSH

Prof. Dr. Matthias Schneider

Physics, Medical and Biological Physics, TU Dortmund



Angaben gem. § 5 TMG:

Eduard Rosert
Zanderstr. 8
60327 Frankfurt